| Date | Time | Source | Headline | Symbol | Company |
| 12/26/2018 | 8:01AM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/26/2018 | 6:01AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 4:42PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 4:41PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 4:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 4:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 4:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 4:38PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 4:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 4:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 4:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 4:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 4:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 3:54PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 9:20AM | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 9:17AM | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 9:13AM | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 9:09AM | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 8:25AM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 8:24AM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 12/13/2018 | 8:20AM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |